| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 19 | 2025 | 517 | 3.930 |
Why?
|
| Leukemia, Myeloid, Acute | 11 | 2025 | 548 | 3.900 |
Why?
|
| Neoplastic Stem Cells | 5 | 2025 | 329 | 1.900 |
Why?
|
| Cell Cycle Proteins | 10 | 2021 | 676 | 1.680 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2025 | 588 | 1.440 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2020 | 169 | 1.300 |
Why?
|
| Transcription Factors | 6 | 2025 | 2344 | 1.260 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 52 | 1.230 |
Why?
|
| Leukemia | 6 | 2021 | 356 | 1.130 |
Why?
|
| Hematopoiesis | 5 | 2022 | 205 | 1.080 |
Why?
|
| Erythroid Cells | 2 | 2024 | 23 | 0.910 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2025 | 74 | 0.870 |
Why?
|
| Homeostasis | 4 | 2021 | 677 | 0.870 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2025 | 156 | 0.840 |
Why?
|
| Anemia | 2 | 2026 | 339 | 0.820 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1868 | 0.820 |
Why?
|
| Estrogens | 2 | 2018 | 421 | 0.820 |
Why?
|
| Dioxygenases | 1 | 2024 | 66 | 0.810 |
Why?
|
| Polycomb Repressive Complex 1 | 4 | 2022 | 26 | 0.800 |
Why?
|
| Histone Chaperones | 1 | 2021 | 9 | 0.710 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2021 | 14 | 0.710 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2005 | 260 | 0.700 |
Why?
|
| CRISPR-Cas Systems | 3 | 2018 | 277 | 0.690 |
Why?
|
| DNA-Binding Proteins | 7 | 2024 | 1891 | 0.680 |
Why?
|
| Mice | 23 | 2025 | 17679 | 0.660 |
Why?
|
| Animals | 31 | 2025 | 33154 | 0.640 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 14 | 0.640 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 3 | 0.620 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2005 | 396 | 0.620 |
Why?
|
| Gene Editing | 3 | 2018 | 197 | 0.610 |
Why?
|
| Azacitidine | 1 | 2019 | 51 | 0.590 |
Why?
|
| DNA Damage | 7 | 2019 | 498 | 0.570 |
Why?
|
| Adipocytes | 1 | 2019 | 167 | 0.560 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 21 | 0.560 |
Why?
|
| Cell Cycle | 5 | 2012 | 587 | 0.560 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 61 | 0.550 |
Why?
|
| Clone Cells | 1 | 2018 | 163 | 0.550 |
Why?
|
| Clonal Evolution | 3 | 2025 | 46 | 0.550 |
Why?
|
| Endoribonucleases | 1 | 2018 | 84 | 0.540 |
Why?
|
| Carcinogenesis | 3 | 2022 | 344 | 0.520 |
Why?
|
| Estrogen Receptor alpha | 2 | 2018 | 424 | 0.520 |
Why?
|
| Stem Cells | 4 | 2019 | 682 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 606 | 0.510 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 4509 | 0.490 |
Why?
|
| Fungal Proteins | 4 | 2004 | 129 | 0.480 |
Why?
|
| Bone Marrow | 1 | 2015 | 308 | 0.410 |
Why?
|
| Spleen | 3 | 2024 | 252 | 0.400 |
Why?
|
| Histones | 3 | 2021 | 503 | 0.380 |
Why?
|
| Energy Metabolism | 3 | 2020 | 749 | 0.370 |
Why?
|
| Protein Kinases | 1 | 2014 | 318 | 0.370 |
Why?
|
| Guided Tissue Regeneration | 1 | 2011 | 3 | 0.360 |
Why?
|
| Oxidative Stress | 1 | 2015 | 756 | 0.340 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2020 | 578 | 0.330 |
Why?
|
| Stem Cell Niche | 2 | 2020 | 57 | 0.310 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2019 | 60 | 0.310 |
Why?
|
| Mutation | 9 | 2025 | 5947 | 0.310 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2311 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2022 | 110 | 0.290 |
Why?
|
| Signal Transduction | 10 | 2020 | 4484 | 0.280 |
Why?
|
| Phosphoproteins | 3 | 2012 | 420 | 0.270 |
Why?
|
| Phleomycins | 2 | 2004 | 6 | 0.260 |
Why?
|
| Humans | 27 | 2026 | 127095 | 0.260 |
Why?
|
| DNA, Fungal | 2 | 2004 | 74 | 0.260 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 3502 | 0.250 |
Why?
|
| IMP Dehydrogenase | 1 | 2025 | 27 | 0.230 |
Why?
|
| Checkpoint Kinase 2 | 5 | 2024 | 35 | 0.220 |
Why?
|
| Aging | 3 | 2026 | 1198 | 0.220 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2012 | 415 | 0.220 |
Why?
|
| Exodeoxyribonucleases | 1 | 2004 | 50 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2025 | 583 | 0.220 |
Why?
|
| Endodeoxyribonucleases | 1 | 2004 | 44 | 0.220 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 48 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2021 | 3716 | 0.210 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 107 | 0.210 |
Why?
|
| Arterial Pressure | 1 | 2024 | 125 | 0.200 |
Why?
|
| Iron | 2 | 2024 | 299 | 0.200 |
Why?
|
| Phosphorylation | 7 | 2020 | 1536 | 0.200 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 208 | 0.190 |
Why?
|
| Proteostasis | 1 | 2022 | 34 | 0.180 |
Why?
|
| Selenium | 1 | 2022 | 15 | 0.180 |
Why?
|
| Gene Deletion | 4 | 2016 | 767 | 0.180 |
Why?
|
| Gene Ontology | 1 | 2021 | 53 | 0.180 |
Why?
|
| NAD | 1 | 2021 | 50 | 0.180 |
Why?
|
| Cell Division | 2 | 2014 | 719 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.170 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 31 | 0.170 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 191 | 0.170 |
Why?
|
| Erythropoiesis | 2 | 2026 | 38 | 0.160 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 57 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4446 | 0.160 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 17 | 0.160 |
Why?
|
| Models, Biological | 2 | 2021 | 1360 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 252 | 0.160 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 89 | 0.160 |
Why?
|
| Cell Proliferation | 4 | 2016 | 2397 | 0.160 |
Why?
|
| Animals, Newborn | 2 | 2021 | 1015 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 202 | 0.150 |
Why?
|
| PAX3 Transcription Factor | 1 | 2019 | 29 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 776 | 0.150 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 290 | 0.150 |
Why?
|
| Acetylation | 1 | 2019 | 181 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2022 | 312 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2019 | 75 | 0.150 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 260 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 108 | 0.150 |
Why?
|
| Methylation | 1 | 2019 | 196 | 0.150 |
Why?
|
| Adipogenesis | 1 | 2019 | 80 | 0.150 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 41 | 0.140 |
Why?
|
| Preleukemia | 1 | 2018 | 1 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2025 | 1168 | 0.140 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 54 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 350 | 0.140 |
Why?
|
| INDEL Mutation | 1 | 2018 | 91 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 80 | 0.140 |
Why?
|
| Cellular Senescence | 1 | 2019 | 197 | 0.130 |
Why?
|
| RNA Interference | 1 | 2019 | 493 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 348 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2019 | 260 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 658 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 358 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2019 | 280 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 948 | 0.130 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 10 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2019 | 676 | 0.120 |
Why?
|
| Protein Binding | 1 | 2019 | 1662 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 573 | 0.120 |
Why?
|
| Replication Protein A | 2 | 2005 | 10 | 0.120 |
Why?
|
| Cell Survival | 2 | 2010 | 840 | 0.110 |
Why?
|
| Female | 9 | 2025 | 68483 | 0.110 |
Why?
|
| Male | 8 | 2025 | 62658 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2799 | 0.110 |
Why?
|
| Apoptosis | 1 | 2021 | 1824 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1771 | 0.110 |
Why?
|
| Prosencephalon | 1 | 2014 | 36 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2896 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 58 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2048 | 0.110 |
Why?
|
| Cell Count | 1 | 2014 | 218 | 0.100 |
Why?
|
| Aged | 5 | 2026 | 20431 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1277 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 577 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 60 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 130 | 0.100 |
Why?
|
| Protein Phosphatase 2C | 2 | 2024 | 59 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2014 | 312 | 0.090 |
Why?
|
| Cytosol | 1 | 2012 | 138 | 0.090 |
Why?
|
| Disease Progression | 1 | 2018 | 2118 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1309 | 0.090 |
Why?
|
| Ovary | 1 | 2014 | 357 | 0.090 |
Why?
|
| DNA Replication | 2 | 2004 | 346 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 24 | 0.080 |
Why?
|
| Neoplasms | 2 | 2024 | 2856 | 0.080 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 46 | 0.080 |
Why?
|
| Pancytopenia | 1 | 2010 | 40 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 151 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2010 | 139 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 236 | 0.080 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2010 | 167 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 198 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 709 | 0.070 |
Why?
|
| Sirolimus | 1 | 2010 | 223 | 0.070 |
Why?
|
| Regeneration | 1 | 2010 | 206 | 0.070 |
Why?
|
| Nerve Net | 1 | 2011 | 244 | 0.070 |
Why?
|
| Integrases | 2 | 2021 | 153 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 60 | 0.060 |
Why?
|
| Melphalan | 1 | 2025 | 43 | 0.060 |
Why?
|
| Mitochondria | 1 | 2010 | 727 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 727 | 0.060 |
Why?
|
| Proteins | 1 | 2010 | 996 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2025 | 265 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 2004 | 59 | 0.060 |
Why?
|
| Prone Position | 1 | 2024 | 30 | 0.050 |
Why?
|
| Genes, cdc | 1 | 2004 | 24 | 0.050 |
Why?
|
| Patient Positioning | 1 | 2024 | 50 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 1 | 2024 | 128 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 320 | 0.050 |
Why?
|
| Methyl Methanesulfonate | 1 | 2003 | 2 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 11 | 0.050 |
Why?
|
| G2 Phase | 1 | 2003 | 38 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2003 | 97 | 0.050 |
Why?
|
| S Phase | 1 | 2003 | 71 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1933 | 0.050 |
Why?
|
| Phylogeny | 1 | 2025 | 687 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2022 | 49 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2022 | 31 | 0.050 |
Why?
|
| Mitosis | 1 | 2003 | 190 | 0.050 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 12 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 511 | 0.040 |
Why?
|
| Oncogenes | 1 | 2022 | 162 | 0.040 |
Why?
|
| Pregnancy | 1 | 2014 | 7395 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 330 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 477 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 92 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2021 | 170 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 656 | 0.040 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 6 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 270 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2013 | 770 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 477 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 190 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 20 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 65 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 103 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 207 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 27801 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1047 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1309 | 0.040 |
Why?
|
| DNA Repair | 2 | 2016 | 549 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2309 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 256 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 256 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 444 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2020 | 742 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 314 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 330 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 808 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 407 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 83 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 130 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 817 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 783 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 898 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1709 | 0.030 |
Why?
|
| Antimitotic Agents | 1 | 2014 | 2 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 365 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 203 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 169 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 211 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2014 | 92 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 219 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2012 | 5 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2013 | 162 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2012 | 30 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 1548 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 24 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 493 | 0.020 |
Why?
|
| Blood Cells | 1 | 2012 | 55 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 93 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 59 | 0.020 |
Why?
|
| Neuroglia | 1 | 2014 | 208 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2014 | 206 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3233 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4972 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 720 | 0.020 |
Why?
|
| United States | 1 | 2026 | 11386 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 649 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 755 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 532 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2564 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1011 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17065 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 4306 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2004 | 69 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 187 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 30435 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 418 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6142 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 308 | 0.010 |
Why?
|
| Replication Protein C | 1 | 2001 | 6 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 604 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2002 | 801 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 2759 | 0.010 |
Why?
|